The Professionalization of Compliance in Thailand: Barriers and Structural Constraints
Asian Business Research Journal · 17.11.2025 · 10 (11) · 25-31
DOI: 10.55220/2576-6759.751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Business Research Journal, online erschienen am 17.11.2025. Verfasst von Alon Kohalny und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This study investigates the current status and developmental challenges of compliance as a profession in Thailand. Through a semi-structured mixed methods approach conducted with 10 Thai compliance officers in 2023 and 2024, the research identifies key institutional, cultural, and market-based barriers to professionalization. Findings indicate limited cross-sector mobility, low engagement with professional associations, and employer-dominated structures that hinder the evolution of compliance into a recognized profession. Drawing on global literature, the paper situates Thailand’s context within the broader journey of compliance from a fragmented function to an emerging profession. It utilizes Perks' (1993) model of professionalization and neo-institutional theory to interpret these dynamics, while considering contributions from Parker (1999), Fanto (2020), Pacella (2019), and others to explore progress, tensions, and future pathways.
Zitieren
APA
Kohalny, A., & Sayag, G. (2025). The Professionalization of Compliance in Thailand: Barriers and Structural Constraints. Asian Business Research Journal, 10(11), 25-31. https://doi.org/10.55220/2576-6759.751
Vancouver
Kohalny A, Sayag G. The Professionalization of Compliance in Thailand: Barriers and Structural Constraints. Asian Business Research Journal. 2025;10(11):25-31. doi:10.55220/2576-6759.751
BibTeX
@article{Kohalny2025,
author = {Kohalny, Alon and Sayag, Gabriel},
title = {The Professionalization of Compliance in Thailand: Barriers and Structural Constraints},
journal = {Asian Business Research Journal},
year = {2025},
volume = {10},
number = {11},
pages = {25--31},
doi = {10.55220/2576-6759.751}
}
EUVIMED